Radiopharm Theranostics breaches ASX listing rule on director issues
Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash
Radiopharm Theranostics (ASX:RAD) breached ASX Listing Rule 10.11 after issuing more shares and options to four directors than shareholders approved, because the Share Purchase Plan offer price was set below the maximum price in the resolutions. The company will sell 4,888,889 excess shares, donate proceeds to charity, and cancel an equal number of excess options.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.